Male 129/Re mice were castrated at 18-24 days of age. At 20 weeks of age they were sacrificed and the body weights and the weights of the anterior tibialis, biceps brachii, extensor digitorum longus, soleus and sternomastoideus were recorded. These muscles were also examined cytologically for total
Explaining the growth of international R&D alliances in China
β Scribed by Jiatao Li; Jing Zhong
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 156 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0143-6570
- DOI
- 10.1002/mde.1079
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This paper explores two key research questions: (1) what are the growth trends of international research and development (R&D) collaborations in China; and (2) what factors determine the choice of international R&D alliance objectives in terms of a research or development orientation? It examines the rapid growth of international R&D alliances in China over the 1995β2000 period and explains multinational firms' motivations for undertaking R&D investments there. Based on the 276 international R&D alliances established in China over the study period, the paper examines the effects of some key alliance factors such as location, nationality and nature of partners, experience of partners, and alliance structure on the choice of international R&D alliance objectives in China. The findings suggest that location, number of partner, nature of local partner, and national origin of foreign partner are significantly related to the formation of researchβoriented alliances. Copyright Β© 2003 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
The International Organization for Crystal Growth (IOCG) Executive Council and General Assembly were held, respectively, on August 10 and 12 2010. A quorum was present at all meetings. Executive Council Meeting 1. The results of the IOCG election of officers and executive committee for 2010-2013 ter
Lin, Fleming and DeGruttola (LFD) address the important problem of estimating the proportion of treatment effect (PTE) explained by a surrogate marker. Problems of interpretation of the measure as well as the theoretical basis of its formulation are well explained. This measure has been introduced t